Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neuhaus

Showing results (771-780 of 830) with videos related to

Pageof 83
Sort By:
Transplantation Proceedings|September 25, 2002
Early cellular markers for the prediction of chronic graft deterioration in a retransplantation modelS G Tullius, U Bachmann, C Heidenhain, et al.
Transplantation Proceedings|April 6, 2005
Induction of heme oxygenase-1 in the donor reduces graft immunogenicityP N A Martins, H Kessler, A Jurisch, et al.
Annals of Surgery|December 1, 2001
Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donorJ Pratschke, G Kofla, M J Wilhelm, et al.
Transplantation Proceedings|August 15, 2002
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growthG Schumacher, M Oidtmann, S Rosewicz, et al.
Clinical Transplantation|December 31, 1997
Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled studyJ M Langrehr, A Kahl, M Meyer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|February 28, 2007
Living related liver transplantation: preoperative magnetic resonance imaging for assessment of hepatic vasculature of donor candidatesF Streitparth, M Pech, S Figolska, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activatorO Guckelberger, W O Bechstein, J M Langrehr, et al.
Transplantation Proceedings|September 2, 1998
Treatment with PGE1 in patients after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Kidney International|February 1, 2007
Donor age intensifies the early immune response after transplantationA Reutzel-Selke, A Jurisch, C Denecke, et al.
The International Journal of Artificial Organs|July 16, 2002
A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver supportA Mundt, G Puhl, A Müller, et al.
Pageof 83

Showing results (771-780 of 830) with videos related to

Sort By:
Pageof 83
Transplantation Proceedings|September 25, 2002
Early cellular markers for the prediction of chronic graft deterioration in a retransplantation modelS G Tullius, U Bachmann, C Heidenhain, et al.
Transplantation Proceedings|April 6, 2005
Induction of heme oxygenase-1 in the donor reduces graft immunogenicityP N A Martins, H Kessler, A Jurisch, et al.
Annals of Surgery|December 1, 2001
Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donorJ Pratschke, G Kofla, M J Wilhelm, et al.
Transplantation Proceedings|August 15, 2002
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growthG Schumacher, M Oidtmann, S Rosewicz, et al.
Clinical Transplantation|December 31, 1997
Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled studyJ M Langrehr, A Kahl, M Meyer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|February 28, 2007
Living related liver transplantation: preoperative magnetic resonance imaging for assessment of hepatic vasculature of donor candidatesF Streitparth, M Pech, S Figolska, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activatorO Guckelberger, W O Bechstein, J M Langrehr, et al.
Transplantation Proceedings|September 2, 1998
Treatment with PGE1 in patients after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Kidney International|February 1, 2007
Donor age intensifies the early immune response after transplantationA Reutzel-Selke, A Jurisch, C Denecke, et al.
The International Journal of Artificial Organs|July 16, 2002
A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver supportA Mundt, G Puhl, A Müller, et al.
Pageof 83